New Mexico, Missouri, Columbia Next for Review As comprehensive Centers; UCLA Decision In October
In Brief: HSAs Would Delay NCI Awards By Nine Months; Mary Lasker Names to Carter Health Group
Committee Kills Pay Raise Bill; Rauscher Probably Will Resign
Conferees Stalled On Money Bill, Running Out Of Time
NCAB Hung Up On removing $ 45 Million Limit For Core Grants
Obey Again – Now He’s Blasting NCI For Not Helping NIOSH
Abstracts Of Papers Presented By Breast Cancer Task Force
Trending Stories
- Prediction markets now allow betting on clinical trial results, FDA decisions
It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake - Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Pour a Scotch, we’re talking clinical trials and prediction markets
- Retraction is not refutation: Why chrono-immunotherapy still deserves scientific investigation
- Mount Sinai oncologist Krystal Cascetta, 40, and her infant daughter die in Somers, NY, home









